Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Oct;35(5):484-93.
doi: 10.1053/j.seminoncol.2008.07.008.

Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group

Affiliations
Review

Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group

Maura O'Leary et al. Semin Oncol. 2008 Oct.

Abstract

The Children's Oncology Group (COG) recently celebrated the milestone of 50 years of pediatric clinical trials and collaborative research in oncology. Our group had its origins in the four legacy pediatric clinical trials groups: the Children's Cancer Group (CCG), the Pediatric Oncology Group (POG), the National Wilms' Tumor Study Group (NWTS), and the Intergroup Rhabdomyosarcoma Study Group (IRSG), which merged in 2000 to form the COG. Over the last 50 years, the survival rates for childhood cancer have risen from 10% to almost 80%. Outcome in acute lymphoblastic leukemia (ALL) has gone from a 6-month median survival to an 80% overall cure rate. We have modified therapies in most major diseases to induce remission with the fewest long-term sequelae. Here we look back on our advances but also look forward to the next 50 years, which will produce even more successful treatments that will be tailored to the specific patient, translating the tools of molecular genetics. Experience has clearly proven that everything we know about the diagnosis and management of childhood cancer is a result of research and the dramatic historical decrease in mortality from childhood cancer is directly related to cooperative group clinical research.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Survival of CCG Patients with ALL 1968 -1997
Fig 2
Fig 2
Overall COG Treatment Trials ALL
Fig 3
Fig 3
Overall COG Treatment Trials AML
Fig 4
Fig 4
Overall COG Treatment Trials Medulloblastoma
Fig 5
Fig 5
Overall COG Treatment Trials High Risk Neuroblastoma

References

    1. Children's Oncology Group. Internal documents
    1. Burchenal JH, Lester RA, Riley JB, et al. Studies on the chemotherapy of leukemia. Cancer. 1948;1:399–412. - PubMed
    1. Farber S, Diamond LK, Mercer RD, et al. Temporary remissions in acute leukemia in children produced by folic acid antagonists, 4-Aminopteroyl-glutamic acid (Aminopterin) N Engl J Med. 1948;238:787. - PubMed
    1. Pearson OH, Eliel LP. Use of adrenocorticotropic hormone (ACTH) and cortisone in lymphomas and leukemias. JAMA. 1950;144:1349. - PubMed
    1. Burchenal JH, Murphy ML, Ellison RR, et al. Clinical evaluation of a new antimetabolite, 6-mercapto purine in the treatment of leukemia and allied diseases. Blood. 1953;8:965–99. - PubMed

Publication types